FORM 10-K FOR DECEMBER 31, 1996

Company

Ernexa Therapeutics Inc.

Filed

April 15, 1997

Period of Report

December 31, 1996

Accession Number

0000944209-97-000485

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →